DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin

Drug Delivery

Volumn 16, Issue 3, 2009, Pages 135-144

  Cheng, Xiaoyun ^a   Zhang, Feng ^a   Zhou, Guangxin ^b   Gao, Shuying ^a   Dong, Lei ^a   Jiang, Wei ^a   Ding, Zhi ^a   Chen, Jiangning ^a   Zhang, Junfeng ^a  

^a NANJING UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biodistribution; DNA chitosan nanocomplex; Doxorubicin; Drug delivery

Indexed keywords

AMINO ACID; DNA PLUS CHITOSAN COMPLEX; DOXORUBICIN; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; PHOSPHATE; UNCLASSIFIED DRUG; WATER; ANTINEOPLASTIC AGENT; CHITOSAN; DNA; FLUORESCEIN; NANOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOPHYSICS; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INJECTION; MOLECULAR WEIGHT; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; RAT; SALMON; SOLUBILITY; TESTIS; ANIMAL; CHEMISTRY; DRUG STABILITY; GENETIC TRANSFECTION; INSTITUTE FOR CANCER RESEARCH MOUSE; MOUSE; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CHITOSAN; DNA; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FLUORESCEIN; HELA CELLS; HUMANS; MICE; MICE, INBRED ICR; MOLECULAR WEIGHT; NANOSTRUCTURES; SOLUBILITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 70349309359     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802605376     Document Type: Article

References (38)

1. Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: therory to practice. Pharmacol Rev, 53, 283-318.
2. Maitani Y, Aso Y, Yamada A, Yoshioka S. (2008). Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Int J Pharm, 356, 69-75.
3. Liu BR, Yang M, Li RT, Ding YT, Qian XP, Yu LX, Jiang XQ. (2008). The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur J Pharm Biopharm, 69, 527-534
4. Lacoeuille F, Hindre F, Moa F, Roux J, Passirani C, Couturier O, Cales P, Le Jeune JJ, Lamprecht A, Benoit JP. (2007). In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int J Pharm, 344, 143-149
5. Li S, Huang L. (1997). In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther, 4, 891-900.
6. Okuda T, Kawakami S, Akimoto N, Niidome T, Yamashita F, Hashida M. (2006). PEGylated lysine dendrimers for tumorselective targeting after intravenous injection in tumor-bearing mice. J Contr Rel, 116, 330-336
7. Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP. (2007). Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomed Nanotech Biol Med, 3, 246-257
8. Nimesh S, Kumar R, Chandra R. (2006). Novel polyallylamine- dextran sulfate-DNA nanoplexes: highly efficient non-viral vector for gene delivery. Int J Pharm, 320, 143-149
9. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. (1994). Biodegradable long-circulating polymeric nanospheres. Science, 263, 1600-1603
10. Santander-Ortega MJ, Csaba N, Alonso MJ, Ortega-Vinuesa JL, Bastos- González D. (2007). Stability and physicochemical characteristics of PLGA, PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: a comparative study. Colloid Surf A Physicochem Eng Asp, 296, 132-140
11. Howard KA, Dash PR, Read ML, Ward K, Tomkins LM, Nazarova O, Ulbrich K, Seymour LW. (2000). Influence of hydrophilicity of cationic polymers on the biophysical properties of polyelectrolyte complexes formed by self-assembly with DNA. Biochim Biophys Acta, 1475, 245-255
12. Hirano S, Seino H, Akiyama Y, Nonaka I. (1989). Biocompatibility of chitosan by oral and intravenous administration. Polym Eng Sci, 59, 897-901.
13. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY. (1998). Preparation of chitosan self-aggregates as a gene delivery system. J Contr Rel, 51, 213-220
14. Artursson P., Lindmark T., Davis S.S., Illum L. (1994). Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res, 11:1358-1361
15. Sato T, Ishii T, Okahata Y. (2001). In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 22, 2075-2080
16. Corsi K, Chellat F, Yahia LH, Fernandes JC. (2003). Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials, 24, 1255-1264
17. Satoh T, Kakimoto S, Kano H, Nakatani M, Shinkai S, Nagasaki T. (2007). In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6- deoxychitosan as a DNA carrier. Carbohyd Res, 342, 1427-1433
18. Thanou M, Florea BI, Langemeier MWE, Verhoef JC, Junginger HE. (2000). N-Trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-s cells) and in vivo (Rats). Pharm Res, 17, 27-31.
19. Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. (2001). Chitosan nanoparticles as delivery systems for doxorubicin. J Contr Rel, 73, 255-267
20. Banerjee T, Mitra S, Singh AK, Sharma RK, Maitra A. (2002). Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm, 243, 93-105.
21. Qaqish RB, Amiji MM. (1999). Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan-mucin interactions. Carbohyd Polym, 38, 99-107.
22. Gao SY, Chen JN, Xu XR, Ding Z, Yang YH, Hua ZC, Zhang JF. (2003). Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm, 255, 57-68.
23. Gummow BD, Roberts GAF. (1985). Studies on chitosan-induced metachromasy, 1. Metachromatic behavior of sodium 2'-hydroxy- 1, 1'-azonaphthalene-4- sulfonate in the presence of chitosan. Makromol Chem, 186, 1239-1244
24. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y. (2000). Doxorubicin-loaded poly(ethylene glycol)-poly(β- benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Contr Rel, 64, 143-153
25. Yamaguchi R, Arai Y, Itoh T. (1981). Preparation of partially N-succinylated chitosans and their cross-linked gels. Carbohydr Res, 88, 172-175
26. Song Y, Onishi H, Machida Y, Nagai T. (1996). Drug release and antitumor characteristics of N-succinyl-chitosan-mitomycin C as an implant. J Contr Rel, 42, 93-100.
27. Schwartz HS. (1973). A fluorometric assay for daunomycin and adriamycin in animal tissues. Biochem Med, 7, 396-404.
28. Onishi H, Machida Y. (1999). Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials, 20, 175-182
29. Wall DA, Wilson G, Hubbard AL. (1980). The galactose-specific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes. Cell, 21, 79-93.
30. Nishikawa M, Ohtsubo Y, Ohno J, Fujita T, Koyama Y, Yamashita F, Hashida M, Sezaki H. (1992). Pharmacokinetics of receptormediated hepatic uptake of glycosylated albumin in mice. Int J Pharm, 85, 75-85.
31. Kaneo Y, Tanaka T, Nakano T, Yamaguchi Y. (2001). Evidence for receptor-mediated hepatic uptake of pullulan in rats. J Contr Rel, 70, 365-373
32. Stolnik S, Daudali B, Arien A, Whetstone J, Heald CR, Garnett MC, Davis SS, Illum L. (2001). The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. Biochim Biophys Acta, 1514, 261-279
33. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Livaniou E, Evangelatos G, Ithakissios DS. (2003). Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm, 259, 115-127
34. Romero EL, Morilla MJ, Regts J, Koning GA, Scherphof GL. (1999). On the mechanism of hepatic transendothelial passage of larger liposomes. FEBS Lett, 448, 193-196
35. Andre T, Daniele DC, Christian DD. (1972). Chemotherapy through lysosomes with a DNA-daunorubicin complex. Nature New Biol, 239, 110-112
36. Chytil P, Etrych T, Koòák È, Ŝí rová M, Mrkvan T, íhová B, Ulbrich K. (2006). Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: Effect of polymer chain modification. J Contr Rel, 115, 26-36.
37. Rodrigues PCA, Beyer U, Schumacher P, Roth T, Fiebig HH, Unger C, Messori L, Orioli P, Paper DH, Mülhaupt R, Kratz F. (1999). Acidsensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution. Bioorgan Med Chem, 7, 2517-2524
38. Kato Y, Onishi H, Machida Y. (2000). Evaluation of N-succinylchitosan as a systemic long-circulating polymer. Biomaterials, 21, 1579-1585